The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Autoreactive Germinal Centers: A Single Autoreactive B Cell Clone Can Drive Autoimmunity

Autoreactive Germinal Centers: A Single Autoreactive B Cell Clone Can Drive Autoimmunity

October 16, 2017 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Until now, scientists have assumed autoimmunity is avoided when T cells restrict the maturation of B cells that have autoreactive B cell receptors (BCRs). This assumption has been turned on its head by detailed research from Soren E. Degn, PhD, a postdoctoral fellow at Harvard Medical School in Boston, and colleagues. The team followed the natural history of autoreactive germinal centers in vivo, and their data provide insight into the breaking of self-tolerance and the maturation of the self-reactive B cell response. Additionally, the research helps contextualize the epitope spreading observed in autoimmune diseases, such as lupus. The investigators published their work in Cell on Aug. 24.1

You Might Also Like
  • Characterization of Autoreactive B Cells in Patients with SLE & RA
  • B Cell Receptor Clones May Predict RA Onset
  • T Cells & Autoimmune Diseases
Also By This Author
  • Fecal Metabolomics Implicate Tryptophan Pathway in Pediatric Spondyloarthritis

The researchers used a mixed chimera mouse model that contained spontaneous, autoreactive germinal centers composed of wild type B cells, as well as 564Igi B cells that target ribonuclear complexes and are capable of initiating autoimmunity. The knockin BCR can be identified in the mice by using anti-idiotype (Id) antibody staining. The researchers followed the mice as they grew and developed their immune systems, finding that at 6 weeks old heterozygous 564Igi mice had robust germinal center B cell populations in spleen and cutaneous lymph nodes. However, they were surprised to discover that Id+ cells were underrepresented in germinal centers relative to the circulating repertoire.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“We made the unexpected observation of widespread epitope spreading in the 564Igi model,” write the authors in their discussion. “In heterozygous 564Igi mice, upward of half of circulating naive mature B cells carried an affinity matured autoreactive BCR derived from the knockin. Yet these cells failed to win in the [germinal center] reaction, giving way to [wild type]-derived cells.”

Researchers then investigated the trajectory of frequencies of Id+ and Id- cells and confirmed that high numbers of wild type-derived B cells were included—not only in the germinal center, but also in downstream plasma and memory cell populations. They concluded that the B cells had undergone somatic hypermutation, which is classically associated with germinal center responses. Thus, a single autoreactive B cell clone was able to drive expansion of wild type B cells in germinal centers.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In heterozygous 564Igi mice, the spontaneous germinal centers primarily contained germinal center B cells with wild type-derived BCRs. The autoreactive germinal centers were polyclonal and evolved toward pauciclonality at varying rates. The most prevalent V segment accounted for approximately 20% of the total sequences, the second most common accounted for approximately 15% and the third most common for 7% of the total sequences. Thus, many of the B cells in the germinal center were distinct from the initial clone and evolved toward dominance of individual clone lineages in a way that was indicative of affinity maturation.

“We observed clonal convergence and selection leading to the predominance of autoreactive V segments in the [wild type]-derived germinal center B cell population, similar to previous observations in autoimmunity and cancer,” they explain. “Serum antibodies displayed epitope spreading, further supported by our finding of [wild type]-derived Ab deposits (IgG2c) in the kidneys of 564Igi mixed chimeras.”

Thus, clonal expansion of wild type B cells in autoreactive germinal centers appeared to be at the heart of epitope spreading and the consequent autoimmune response. Even more importantly, researchers concluded that “self-reactive 564Igi B cells are sufficient to break tolerance and induce the formation of autoreactive [germinal centers], which are predominantly composed of [wild type]-derived cells.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

Reference

  1. Degn SE, van der Poel CE, Firl DJ, et al. Clonal evolution of autoreactive germinal centers. Cell. 2017 Aug 24;170(5):913-926.e19. doi: 10.1016/j.cell.2017.07.026.

Pages: 1 2 | Multi-Page

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: Autoimmune disease, autoreactive germinal centers, B cells

You Might Also Like:
  • Characterization of Autoreactive B Cells in Patients with SLE & RA
  • B Cell Receptor Clones May Predict RA Onset
  • T Cells & Autoimmune Diseases
  • T Cell Exhaustion: A New Strategy for Treating Autoimmune Disease

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.